首页> 外文会议>World Congress of International Federation of Automatic Control >A MODEL BASED ANALYSIS OF ANTI-CD4 THERAPY AS ADJUVANT TO HAART INTERRUPTION
【24h】

A MODEL BASED ANALYSIS OF ANTI-CD4 THERAPY AS ADJUVANT TO HAART INTERRUPTION

机译:基于模型的抗CD4疗法分析,作为HAART中断的佐剂

获取原文

摘要

Interruption of Highly Active Antiretroviral Therapy -^sHAART can be for a variety of reasons. The reasons could be salvage therapy, autoimmunization or to reduce the total time that the patient is on therapy. The problem with HAART interruption is that the virus starts to rebound immediately following HAART cessation, and there is an associate decline in CD4{sup}+ T cell counts. There is therefore a need to employ other therapeutic options that will slow down the viral rebound and/or CD4{sup}+ T cell decline during HAART interruption. This paper presents a model based analysis of how the duration of HAART interruption can be extended by CD4{sup}+ T specific therapies, for patients who initiate therapy during the chronic infection stage. For these patients, the purpose of interruptions is primarily to reduce the time on HAART.
机译:高活性抗逆转录病毒治疗的中断 - ^ Shaart可以出于各种原因。原因可以是挽救治疗,自身免疫或减少患者在治疗的总时间。 HAART中断的问题是,在HAART停止后,病毒开始将立即反弹,并且CD4 {sup} + t细胞计数有助理下降。因此,需要采用其他治疗选项,将减缓病毒反弹和/或CD4 {Sup} + T细胞在HAART中断期间下降。本文提出了一种基于模型的分析,对HAART中断的持续时间可以通过CD4 {SUP} + T特异性疗法来扩展,用于在慢性感染阶段发起治疗的患者。对于这些患者,中断的目的主要是为了减少HAART的时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号